Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Clinical Dermatology Open Access Journal Research Article 4 min read

Endocrinal Misbalance in Acne Patients with Postacne Sings

Endocrinal Misbalance in Acne Patients with Postacne Signs
ISSN: 2574-7800  10.23880/cdoaj-16000212  Received: April 11, 2020  Published: May 18, 2020
  views
 13 references
 1 table
PDF
Keywords
Postacne Hypertrichosis Prolactin Endocrinologic disbalance
Abstract

Objectives: Endocrine factors influence acne and it can also influence postacne signs formation. Therefore study of hormonal levels in acne patients with postacne signs formation is very important. The aim was to study levels of hormones and estimate changes of each studied hormone. Methods: 102 female out-patients from Kyiv city dermatovenereologic hospital and other bases of the department of dermatovenereology with different clinical forms of acne were examined. Clinical and hormonal tests were done. Results: 52.94% acne patients had different hormonal misbalances. The most typical changes were increased levels of prolactin and decreased levels of progesterone. The most typical changes in subgroup of acne patients with comorbidities were increased levels of 17α-hydroxyprogesterone and prolactin. Conclusions: Hormonal misbalance can lead to late acne and more severe acne manifestations including postacne signs. Additional endocrinologic conditions can increase such an influence. Correction and control of endocrinologic disbalance can improve efficacy of acne treatment and prevent formation of postacne signs.

Introduction

According to Ukrainian and foreign literature the interest to the problem of acne and postacne signs is growing. Because of wide spread of acne and postacne it is important for modern dermatology and esthetic medicine to study mechanisms of its development [1, 2, 3, 4].

There are several methods of medical correction of postacne signs (topical treatment, injections and surgery) but none of them satisfy patients or doctors and guarantee good cosmetic effect [2, 5, 6, 7, 8, 9, 10, 11, 12]. Development of new methods of postacne treatment is actual. It is important to study different aspects of pathogenesis of postacne for that. Nevertheless, there are several modern explanations of acne and postacne formation but it is multifactorial problem and all these factors have to be investigated. Typically acne disappears without any signs but in about 40% of acne patients postacne is present. It happens because of evolution of acne rash elements. Scars, post inflammatory erythema and dishromia belong to postacne signs. Duration of acne correlated with postacne signs formation. Global alliance acne treatment informed that duration of acne, deep inflammatory skin rash elements, and traumatization by patients and inadequate treatment are main reasons of postacne signs development [13]. Erythema and pigmentations are results of epidermal changes and scars are results of dermal traumatization. Hypertrophic or celoid scars are formed in case of excessive synthesis of connective tissue. It is most typical on the breast, between scapula and more rear on lower parts of jaws. But other types of scars are more frequent on the face. Atrophic scars are more typical for face than for extrafacial regions.

Endocrine factors influence acne and it can also influence postacne signs formation. Therefore study of hormonal levels in acne patients with postacne signs formation is very important.

The aim was to study levels of hormones and estimate changes of each studied hormone.

Methods

Patients with acne and postacne signs from Kyiv city dermatovenereologic hospital and other bases of the department of dermatovenereology were involved. In total 102 female out-patients with different clinical forms of acne were examined. All patients had clinical and laboratory examinations. Age of patients was 18-44 years old. Majority of patients were 20-30 years old.

The following laboratory tests were done for all patients:

  • Luteinizing hormone
  • Follicle-stimulating hormone
  • Prolactin
  • Thyroid-stimulating hormone
  • 17α-Hydroxyprogesterone (17ОН)
  • Dihydrotestosterone
  • Testosterone
  • Sex hormone binding globulin
  • Dehydroepiandrosterone sulfate
  • Free testosterone index
  • Estradiol (Е2)
  • Progesterone Statistic programs STATISTICA 10.0 En and Medstat were used. For statistical significance the value of р <0.05 was used.

Results and Discussion

From 102 studied women with acne about 90% had level 2 of acne severity. 17 patients also had hypertrichosis and 4 patients had diffuse alopecia. One patient had autoimmune thyroiditis and another one myasthenia.

52.94% patients had different hormonal misbalances (Table 1). The most typical changes were increased levels of prolactin (n=21) and decreased levels of progesterone (n=23).

Only one patient with acne and hypertrichosis had all normal tests results. It showed that coexistence of hypertrichosis can increase hormonal misbalance and probably influence the course of acne and postacne signs. The most typical changes in this subgroup of acne patients were increased levels of 17α-hydroxyprogesterone and prolactin. In patients without comorbidities the most frequent change was decrease of progesterone (Table 1).

Hormonal misbalance can lead to late acne and more severe acne manifestations including postacne signs. Additional endocrinologic conditions can increase such an influence.

Correction and control of endocrinologic disbalance can improve efficacy of acne treatment and prevent formation of postacne signs.

AgeHormonal changesAcne severity gradeComorbidities
18Prolactin, 17ОН, Dihydrotestosteron1
24Prolactin, 17ОН2Hypertrichosis
25Progesterone2
18Progesterone2
23Progesterone3
2817ОН, Prolactin,2Myasthenia
Testosterone
29Progesteron1Hypertrichosis
23Progesterone2Hypertrichosis
30Prolactin, Testosterone, 17 ОН1
33Dehydroepiandrosterone sulfate, Progesterone2
3017ОН, Sex hormone binding globulin3
30Prolactin2
20Dehydroepiandrosterone sulfate, Progesterone2Hypertrichosis
27Estradiol1
30Sex hormone binding globulin1Diffuse alopecia
22Progesterone2
25Prolactin, 17ОН, Progesterone2
22Prolactin2
Progesterone
28Prolactin2Hypertrichosis
2817 ОН2
18Progesterone2
31Prolactin2
26Prolactin, Testosterone, 17 ОН, Sex hormone binding
globulin
2
1817 ОН, Testosterone2
32Prolactin2Diffuse alopecia
34Sex hormone binding globulin2
22Prolactin, Estradiol2
36Sex hormone binding globulin, Dihydrotestosterone,1Diffuse alopecia
Progesterone
1817 ОН, Testosterone2
41Estradiol, Progesteron2
21Dehydroepiandrosterone sulfate, Progesterone2
25Prolactin2
21Prolactin2
Progesterone
26Progesterone2
29Prolactin2
23Progesterone1
20Prolactin2Hypertrichosis
Progesterone
2917 ОН2
2317 ОН, Sex hormone binding globulin,
Dehydroepiandrosterone sulfate
2Hypertrichosis
25Prolactin, Progesterone, Testosterone,
Dehydroepiandrosterone sulfate
2Hypertrichosis
18Testosterone, Progesterone2Diffuse alopecia
20Dehydroepiandrosterone sulfate2Hypertrichosis
18Testosterone2
18Testosterone, Dehydroepiandrosterone sulfate, Thyroid-
stimulating hormone, Progesterone
2Hypertrichosis
3817 ОН2Hypertrichosis
35Prolactin, Testosterone2
20Prolactin2
18Dehydroepiandrosterone sulfate, Progesterone2
20Progesterone2Hypertrichosis
2517 ОН2
41Thyroid-stimulating hormone, 17ОН2Autoimmune
thyroiditis
28Prolactin2
25Testosterone2
25Prolactin, 17ОН, Dehydroepiandrosterone sulfate, Sex
hormone binding globulin
2Hypertrichosis

Table 1: Hormonal changes in acne patients.

References

  1. Soliman YS, Horowitz R, Hashim PW, Nia JK, Farberg AS, et al. (2018) Update on acne scar treatment. Cutis. 102(1): 21;25;47;48.
  2. Goodman GJ (2000) Postacne scarring: a review of its pathophysiology and treatment. Dermatol Surg 26(9): 857-871.
  3. Bardova KO (2015) Some Aspects of Scar Treatment. Dermatologia ta venereologia 1: 56-62.
  4. Kolcheva PA, Kolcheva LS, Kruglova OV (2015) Physiotherapeutic methods in the treatment of acne and postacne. Fizioterapevt 3: 31-37.
  5. Geynits AV, Kiani SA, Okushko S (2013) Application of combined epidermal and dermal fractional ablation in the treatment of atrophic scars in the supply chain. Vestnik esteticheskoy meditsiny 4: 58--77.
  6. Kachuk, Yu V ( 2014) Modern possibilities of correction of supply chain. Zhurnal dermatovenerologії ta kosmetologії іm. M.O.Torsuєva 1: 96-98.
  7. Kolcheva PA, Zhukova OV (2015) Correction of supply by the method of exposure to radiofrequency fractional micrneedles. Fizioterapevt 5: 15-20.
  8. Lazarenko NN, Supova MV, Trunova OV (2015) Microcurrent therapy in the treatment of patients with a supply. topical issues of modern medicine. Fizioterapevt 1: 8-10.
  9. Urakova DS, Pozdeeva EV (2016) Erbium laser in correction supply box. Apparatnaya kosmetologiya 2: 40-43.
  10. Cachafeiro T, Escobar G, Maldonado G (2016) Comparison of Nonablative Fractional Erbium Laser 1,340 nm and Microneedling for the Treatment of Atrophic Acne Scars: A Randomized Clinical Trial. Dermatol Surg 42: 232-241.
  11. Erbağci Z, Akçali C (2000) Biweekly serial glycolic acid peels vs. long-term daily use of topical low-strength glycolic acid in the treatment of atrophic acne scars. Int J Dermatol 39(10): 789-794.
  12. Zawar VP, Agarwal M, Vasudevan B (2015) Treatment of Postinflammatory Pigmentation Due to Acne with Q-Switched Neodymium-Doped Yttrium Aluminum Garnet In 78 Indian Cases. J Cutan Aesthet Surg 8(4): 222-226.
  13. Thiboutot DM, Dréno B, Abanmi A, Alexis AF, Araviiskaia E, et al. (2018) Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 78(2): S1-S23.e1.

Cite this article

BibTeX
APA
RIS
@article{endocrinal2020,
  title   = {Endocrinal Misbalance in Acne Patients with Postacne Sings},
  author  = {Endocrinal Misbalance in Acne Patients with Postacne Signs},
  journal = {Clinical Dermatology Open Access Journal},
  year    = {2020},
  volume  = {5},
  number  = {2},
  doi     = {10.23880/cdoaj-16000212}
}
Endocrinal Misbalance in Acne Patients with Postacne Signs (2020). Endocrinal Misbalance in Acne Patients with Postacne Sings. Clinical Dermatology Open Access Journal, 5(2). https://doi.org/10.23880/cdoaj-16000212
TY  - JOUR
TI  - Endocrinal Misbalance in Acne Patients with Postacne Sings
AU  - Endocrinal Misbalance in Acne Patients with Postacne Signs
JO  - Clinical Dermatology Open Access Journal
PY  - 2020
VL  - 5
IS  - 2
DO  - 10.23880/cdoaj-16000212
ER  -